Colm O’Morain

Active 1980–2025

Also published as
Colm O’Moráin
100
Papers
30,967
Citations
76
h-index
99
i10-index

Citations

Citations per year for Colm O’Morain1970: 1 citations1983: 2 citations1984: 3 citations1985: 8 citations1986: 4 citations1987: 10 citations1988: 14 citations1989: 17 citations1990: 25 citations1991: 24 citations1992: 24 citations1993: 21 citations1994: 19 citations1995: 14 citations1996: 24 citations1997: 35 citations1998: 47 citations1999: 87 citations2000: 134 citations2001: 129 citations2002: 227 citations2003: 228 citations2004: 227 citations2005: 225 citations2006: 255 citations2007: 230 citations2008: 176 citations2009: 216 citations2010: 187 citations2011: 207 citations2012: 166 citations2013: 256 citations2014: 256 citations2015: 245 citations2016: 226 citations2017: 200 citations2018: 190 citations2019: 610 citations2020: 683 citations2021: 550 citations2022: 453 citations2023: 458 citations2024: 718 citations2025: 390 citations2026: 13 citations1971–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,114 citing papers, 17.8% of this breakdownChina: 1,000 citing papers, 8.4% of this breakdownUnited Kingdom: 926 citing papers, 7.8% of this breakdownItaly: 689 citing papers, 5.8% of this breakdownGermany: 615 citing papers, 5.2% of this breakdownFrance: 615 citing papers, 5.2% of this breakdownCanada: 486 citing papers, 4.1% of this breakdownJapan: 411 citing papers, 3.4% of this breakdownSpain: 356 citing papers, 3% of this breakdownNetherlands: 344 citing papers, 2.9% of this breakdownAustralia: 289 citing papers, 2.4% of this breakdownBelgium: 258 citing papers, 2.2% of this breakdown
0%17.8%Other 31.8%

Fields

  • Medicine55.3%
  • Biochemistry, Genetics and Molecular Biology33%
  • Immunology and Microbiology7.3%
  • Agricultural and Biological Sciences0.9%
  • Nursing0.7%
  • Neuroscience0.6%
  • Other2.2%

Topics

  • Helicobacter pylori-related gastroenterology studies13.9%
  • Inflammatory Bowel Disease9.5%
  • Microscopic Colitis5%
  • Clostridium difficile and Clostridium perfringens research3.7%
  • Gastric Cancer Management and Outcomes3.5%
  • Gut microbiota and health3.3%
  • Other61.1%

Coauthors

All papers

Open in search
  1. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

    Authors: , , , , , , , , , , , , , , - Gut 2022 cited by 1,352

  2. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

    Authors: , , , , , , , , , , , , , , , , , - Gut 2016 cited by 2,924

  3. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2024 cited by 453

  4. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2001 cited by 5,606

  5. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

    Authors: , , , , , , , , , , , , - Gut 2012 cited by 2,259

  6. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

    Authors: , , , , , , , , - Gastroenterology 2021 cited by 181

  7. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting

    Authors: , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 120

  8. Geographical variability and environmental risk factors in inflammatory bowel disease

    Authors: , , , , , , , , - Gut 2013 cited by 589

  9. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Travis, Flávio Steinwurz, Dan Turner, Parambir S. Dulai, Vipul Jairath, Iris Dotan, María T. Abreu, Remo Panaccione, Silvio Danese - Gastroenterology 2021 cited by 165

  10. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Antibiotics 2021 cited by 111

  11. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jolien Schol, Arkady Sheptulin, Annemieke Smet, Andreas Stengel, О. А. Сторонова, Martin Storr, Hans Törnblom, Tim Vanuytsel, Mónica Velosa, Marek Waluga, Natalia Zárate, Frank Zerbib - Neurogastroenterology & Motility 2021 cited by 160

  12. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Endoscopy 2011 cited by 678

  13. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2010 cited by 1,493

  14. High prevalence of overweight and obesity in adults with Crohn's disease: Associations with disease and lifestyle factors

    Authors: , , , , , - Journal of Crohn s and Colitis 2012 cited by 159

  15. Development of an index to define overall disease severity in IBD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Pallone, Simon Travis, Julián Panés, Jean‐Frédéric Colombel, Stephen B. Hanauer, Laurent Peyrin‐Biroulet - Gut 2016 cited by 151

  16. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach

    Authors: , , , , , , , , , , - Gut 2010 cited by 313

  17. European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - United European Gastroenterology Journal 2020 cited by 71

  18. Population screening and treatment of Helicobacter pylori infection

    Authors: , , - Nature Reviews Gastroenterology & Hepatology 2017 cited by 182

  19. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , María Caldas, María G. Donday, Oleg Shvetz, Françis Mégraud, Colm O’Morain, Javier P. Gisbert - Clinical Gastroenterology and Hepatology 2019 cited by 94

  20. Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)

    Authors: , , , - Helicobacter 2019 cited by 80

  21. CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2002 cited by 990

  22. Review: Improving compliance with Helicobacter pylori eradication therapy: when and how?

    Authors: , , - Therapeutic Advances in Gastroenterology 2009 cited by 99

  23. A network meta‐analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection

    Authors: , , , , , , , - United European Gastroenterology Journal 2019 cited by 76

  24. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Finlay Macrae, Gerrit A. Meijer, Joshua Melson, Colm O’Morain, Susan Parry, Linda Rabeneck, David F. Ransohoff, Roque Sáenz, Hiroshi Saito, Silvia Sanduleanu‐Dascalescu, Robert E. Schoen, Kevin Selby, Harminder Singh, R. Steele, Joseph J.�Y. Sung, Erin L. Symonds, Sidney J. Winawer - Gut 2023 cited by 49